Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4323811 | Brain Research | 2015 | 14 Pages |
Abstract
Daily oral intake of ERV, at a clinically relevant dose, protects the brain from ischemic stroke, and also enhances the learning function in normal mice. As millions of people are currently taking the drug safely, and have been for many years in some cases, there is a need to test the inhibitory actions of the drug on progressive dementia encountered in humans with recurrent ischemic attacks or Alzheimer's disease.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Yukako Nakajo, Dong Yang, Jun C Takahashi, Qiang Zhao, Hiroharu Kataoka, Hiroji Yanamoto,